La Corona de Cobre Project
Global Hunter's La Corona de Cobre project is over 18,000 hectares of land located in the Coast Range of the Andean Cordillera, Chile, an area often referred to as the Chilean Iron Belt. The property is on the Pan American Highway, 70-kilometres north of the port city La Serena.
The property is located at the southern end of the Atacama Fault Zone, a north-northeast regional feature that stretches for over 1,000 kilometres and hosts several large copper deposits in Chile including Phelps Dodge's Candelaria (400 million tonnes grading 0.95% copper and 0.2% gold) and Anglo-American's Manto Verde (100 million tonnes averaging 0.80% copper) deposits.
- Over 18,000 hectare land package
- 70km North of La Serena, Chile (deep water port)
- Pan American Highway and major transmission lines pass through property
- Readily accessible water
- Railways adjacent to property
- 15 mineralized shear zones ranging from 20 to 250m in widths and 0.5 to 9.0km in length
- 1 of the 15 shear zones (Las Posadas), has been drill tested
Global Hunter's La Corona de Cobre hosts a swarm of 15 shear zones ranging from 10 to 150 metres in thickness and from one-half to nine-kilometres in length.
To learn more about Global Hunter visit: http://www.globalhunter.ca
SMF Energy Corporation (Nasdaq:FUEL) a leading energy logistics company providing efficient, just in time distribution of petroleum products and chemicals, announced its earnings and results for the first quarter of fiscal year 2011 ended September 30, 2010. Net income was $114,000 in the first quarter of fiscal year 2011, compared to a net income of $20,000 in the same period of the prior year, an improvement of $94,000. EBITDA(1) (a non-GAAP measure) was $953,000 in the first quarter of fiscal 2011 compared to $1.1 million in the same period of the prior year, a decrease of $181,000. We increased our volumes by 6% to 17.9 million gallons during the first quarter this fiscal year from 16.9 million during the first quarter of fiscal 2010. The increase in volumes is primarily the result of the expansion into three new markets that we initiated during the second quarter of last year.
SMF Energy Corporation supplies specialized transportation and distribution services for petroleum products and chemicals. The company provides commercial mobile and bulk fueling, lubricant and chemical distribution, emergency response services, and transportation logistics to the trucking, manufacturing, construction, shipping, utility, energy, chemical, telecommunications, and government services industries.
Power3 Medical Products, Inc. (OTC:PWRM)
PWRM recently delivered four poster presentations at the 2010 ICAD. These presentations discussed PWRM’s diagnostic test, NuroPro, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.
“In preparation for commercialization, our objective at this meeting was to show how Power3’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief Scientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”
“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” commented Helen R. Park, MS, CEO of PWRM, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”
“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
To learn more about PWRM visit: http://www.Power3Medical.com
Digirad Corporation (Nasdaq:DRAD) announced that management is scheduled to make an investor presentation at the 2010 Southern California Investor Conference on Thursday, December 9th, at 12:30 PM Pacific Time. The one-day conference is being held at The Luxe Sunset Bel Air in Los Angeles. Digirad is a leading provider of diagnostic imaging products, and personnel and equipment leasing services. For more information, please visit www.digirad.com. Digirad® is a registered trademark of Digirad Corporation.
Digirad Corporation provides diagnostic imaging products, and personnel and equipment leasing services primarily in the United States. The company operates in two segments, Digirad Imaging Solutions and Product. The Digirad Imaging Solutions segment offers various personnel and equipment leasing services for physicians to perform nuclear imaging, echocardiography, vascular ultrasound, or any combination of these procedures in their offices by leasing the imaging system, certified personnel, and other support required to perform imaging.****************************
icad Inc. (Nasdaq:ICAD) an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announced its schedule of events at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, from November 28 through December 3, 2010. "At the RSNA this year, iCAD will continue to work with thought leaders in the radiology field and healthcare advocates to change the diagnostic paradigm for breast, prostate and colon cancers so that more people can access advanced imaging solutions for earlier detection of these prevalent cancers," said Ken Ferry, President and CEO of iCAD. "Our recently FDA cleared CT Colonography technology, VeraLook™, is expected to generate great interest this year, as continued research and data analysis show the promise of virtual colonography for improving patient adherence to guidelines supporting screening for colorectal cancer. Our leading-edge technologies for CAD applied to digital mammography and breast MRI are also expected to draw continued attention to this audience of more than 60,000 medical, scientific and corporate professionals."
iCAD, Inc. provides image analysis and workflow solutions that enable radiologists and other healthcare professionals to identify pathologies and pinpoint cancer earlier. The company offers a range of expandable computer-aided detection (NYSEARCA:CAD) systems for digital and film-based mammography systems that include SecondLook systems, which analyses the data and automatically identifies and marks suspicious regions in the images; SecondLook Digital, a computer server residing on a customer?s network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to picture archiving and communication systems and/or review workstations; and SecondLook 300 and SecondLook 200 products that enable cancer detection and for use at smaller facilities.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from a third party for (thirty) days of advertising for Global Hunter Corp. (TSX Venture Exchange (TSX.VOB) and the Frankfurt Stock Exchange (FSE:G5D). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).